Becker's Healthcare September 13, 2024
Erica Carbajal

Tampa, Fla.-based Moffitt Cancer Center and drugmaker AstraZeneca are collaborating to accelerate the development of CAR-T cell and T cell receptor therapies.

“We are excited to collaborate with AstraZeneca to push the boundaries of what’s possible in cancer treatment,” Patrick Hwu, MD, Moffitt’s president and CEO, said in a Sept. 13 news release. “By combining our clinical expertise with AstraZeneca’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Partnerships, Pharma / Biotech, Provider, Trends
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
Moderna gets $590M from US government for bird flu vaccine
Why costly gene therapy is top of mind for benefits administrators
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial

Share This Article